查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828132

2025年全球植入式心臟整流去顫器市場報告

Implantable Defibrillators Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式心臟整流去顫器市場穩定成長，預計2024年將達55.4億美元，2025年將達56.9億美元，複合年成長率為2.8%。預測期內的成長歸因於心臟病盛行率的上升、臨床證據和研究、人口老化、認知和教育的提高以及合作與夥伴關係的加強。

植入式心臟整流去顫器市場預計將在未來幾年強勁成長，到2029年將達到72.3億美元，年複合成長率（CAGR）為6.1%。預測期內的成長可歸因於遠端監控與遠端醫療的整合、適應症的不斷擴大、對心臟衰竭管理的日益重視、個人化醫療方法以及全球醫療保健基礎設施的擴展。預測期內的主要趨勢包括小型化和設計創新、遠端監控和連接、個人化治療方法、無導線植入式心臟整流去顫器以及電池技術的進步。

植入式心臟整流去顫器是一種小型電池供電裝置，植入胸腔後用於調節異常心律。它持續監測心律，並在檢測到危險或不規則的模式時發出電擊以恢復正常心律。

植入式心臟整流去顫器的主要類型包括單植入式心臟整流去顫器、植入式心臟整流去顫器和雙心室植入式心臟整流去顫器。植入式心臟整流去顫器僅將一個右心室ICD電擊線圈導線植入心臟右心室。這些設備持續監測患者的心率和心律，並可對心臟施加電擊。主要的植入方式是經靜脈和皮下，醫院、診所、門診手術中心和其他終端使用者均採用此方法。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供植入式心臟整流去顫器的市場統計數據，例如全球市場規模、各地區市場佔有率、競爭對手的植入式心臟整流去顫器佔有率、詳細的植入式心臟整流去顫器植入式心臟整流去顫器市場、市場趨勢和商機，以及在植入式心臟整流去顫器行業取得成功所需的數據。植入式心臟整流去顫器市場研究報告提供了全面的展望，並對產業現狀和未來進行了詳細分析。

我們預測未來五年該市場將成長6.1%，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自日本和瑞典等主要地區的高壓電容器和鈦合金外殼徵收關稅直接影響美國，從而導致救生心臟設備的供應減少，以及心臟麻痹預防設備價格上漲。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

心臟麻痹盛行率預計將上升，這將推動植入式心臟整流去顫器市場的成長。心臟麻痹(SCA) 是指心臟意外停止跳動的一種疾病，而植入式心臟整流去顫器透過檢測和糾正可能導致 SCA 的異常心律，在提供挽救生命的治療方面發揮著至關重要的作用。根據《美國心臟病學會雜誌》報道，SCD 每年在美國導致 18.5 萬至 45 萬人死亡，佔所有死亡人數的 7% 至 18%。因此，心臟麻痹盛行率的上升是推動植入式心臟整流去顫器市場成長的關鍵因素。

預計糖尿病盛行率的上升將推動未來植入式心臟整流去顫器市場的擴張。糖尿病是一種以高血糖值為特徵的慢性代謝性疾病，隨著時間的推移，會對心臟、血管、眼睛、腎臟和神經造成嚴重損害。植入式心臟整流去顫器(ICD) 對於管理糖尿病患者至關重要，尤其是那些有心臟猝死風險的患者。研究表明，ICD 可有效降低包括糖尿病患者在內的嚴重心肌功能障礙患者的心律不整死亡率和總死亡率。例如，2024 年 6 月，英國管理機構 NHS England 報告稱，2023 年在 GP 註冊的患者有 3,615,330 名被診斷為非糖尿病性高血糖症，也稱為糖尿病前期。因此，糖尿病盛行率的上升正在推動植入式心臟整流去顫器市場的成長。

植入式心臟整流去顫器市場的一個顯著趨勢是各大公司都注重產品創新。這些公司正專注於開發新產品以保持競爭力。例如，2023 年 12 月，總部位於愛爾蘭的醫療設備公司Medtronic宣布推出一種新型植入式心臟整流去顫器，稱為 Aurora 血管外 ICD。與傳統的經靜脈 ICD 不同，該裝置插入左腋下皮下，在心臟麻痹和持續心律調節器治療期間提供去心房顫動。它使用 Epsila 導線，以微創方式連接到胸骨下方的心臟。此外，該植入還採用了Medtronic的 SmartSense 技術（旨在降低不必要電擊的風險）和 SureScan 技術（讓患者在配戴裝置時可以進行 MRI 掃描）。

植入式心臟整流去顫器市場的主要企業也專注於推出具有尖端功能的先進心律管理 (CRM) 設備，以推動市場收益。這些配備創新技術的設備可以有效監測和管理心臟問題。例如，2023 年 10 月，總部位於法國的心臟節律器和植入式心律去心房顫動開發商和製造商 MicroPort CRM 在日本推出了 ULYS植入式心臟整流去顫器(ICD) 和 INVICTA去心房顫動導線。由於最尖端科技和低電流消耗，ULYS ICD 的使用壽命預計將比傳統 ICD 長得多。 INVICTA去心房顫動顫導線旨在持續檢測來自心臟右心室的電訊號，並在發生可能致命的心室心搏過速時發出去心房顫動電擊或起搏治療。

2022年12月，美國醫療保健產品製造商強生醫療以166億美元收購了Abiomed。這項策略性措施使強生能夠透過整合Abiomed的心臟恢復技術，增強其全球領先的Biosense Webster電生理業務，並擴大其在快速成長的循環系統領域的產品組合，其中包括植入式心臟整流去顫器。 Abiomed是美國的循環系統醫療技術供應商，專門治療心臟衰竭和冠狀動脈疾病。

植入式心臟整流去顫器市場的主要企業包括波士頓科學公司、LivaNova PLC、BIoTronik SE & Co KG、微創醫療科學公司、美敦力公司、聖猶達醫療公司、雅培實驗室、Sorin Group Italia Srl、日本光電公司、荷蘭皇家飛利浦公司、福田電株式會社. Corporation、Defibtech LLC、HeartSine Technologies LLC、Schiller AG、CU Medical Systems Inc.、邁瑞醫療國際有限公司、深圳邁瑞生物醫療電子股份有限公司、北京邁瑞生物醫療電子有限公司、Bexen Cardio SL、Pacemaker Technologies 和 EBR Systems Inc.。

2024年，北美是植入式心臟整流去顫器市場最大的地區。預計亞太地區將成為全球植入式心臟整流去顫器市場預測期內成長最快的地區。植入式心臟整流去顫器市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。

植入式心臟整流去顫器市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、美國、英國、加拿大、義大利、西班牙

植入式心臟整流去顫器市場包括心外膜植入式心臟整流去顫器、胸骨下植入式心臟整流去顫器以及帶心房感應的單腔ICD的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式心臟整流去顫器：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球植入式心臟整流去顫器市場：成長率分析
  • 全球植入式心臟整流去顫器市場表現：規模與成長，2019-2024
  • 全球植入式心臟整流去顫器市場預測：規模與成長，2024-2029年，2034年
  • 全球植入式心臟整流去顫器：總目標市場（TAM）

第6章 市場細分

  • 全球植入式心臟整流去顫器市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 單植入式心臟整流去顫器
  • 雙腔植入式心臟整流去顫器
  • 雙心室植入式心臟整流去顫器
  • 全球植入式心臟整流去顫器市場（按手術類型、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 經靜脈植入式心臟整流去顫器
  • 皮下植入式心臟整流去顫器
  • 全球植入式心臟整流去顫器市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 門診手術中心
  • 其他
  • 全球植入式心臟整流去顫器市場：單植入式心臟整流去顫器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 標準單腔ICD
  • 無導線單腔ICD
  • 全球植入式心臟整流去顫器市場：雙腔植入式心臟整流去顫器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 標準膽管 ICD
  • 先進的膽管 ICD
  • 全球植入式心臟整流去顫器市場：雙心室植入式心臟整流去顫器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 標準雙心室ICD
  • 先進的雙心室 ICD 及 CRT

第7章 區域和國家分析

  • 全球植入式心臟整流去顫器市場：按地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球植入式心臟整流去顫器市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入式心臟整流去顫器市場：競爭格局
  • 植入式心臟整流去顫器市場：公司簡介
    • Boston Scientific Corporation
    • LivaNova PLC
    • BIoTronik SE & Co KG
    • MicroPort Scientific Corporation
    • Medtronic plc

第31章：其他領先和創新企業

  • St. Jude Medical Inc.
  • Abbott Laboratories
  • Sorin Group Italia Srl
  • Nihon Kohden Corporation
  • Koninklijke Philips NV
  • Fukuda Denshi Co Ltd.
  • Progetti Srl
  • Imricor Medical Systems Inc.
  • ZOLL Medical Corporation
  • Physio-Control International Inc.
  • Cardiac Science Corporation
  • Defibtech LLC
  • HeartSine Technologies LLC
  • Schiller AG
  • CU Medical Systems Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年植入式心臟整流去顫器市場：提供新機會的國家
  • 2029年植入式心臟整流去顫器市場：細分市場帶來新機會
  • 2029年植入式心臟整流去顫器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24223u

An implantable defibrillator is a small, battery-operated device inserted into the chest to regulate abnormal heart rhythms. It continuously monitors the heart's rhythm, and if it detects a dangerous or irregular pattern, it delivers an electrical shock to restore a normal rhythm.

The primary types of implantable defibrillators include single-chambered implantable defibrillators, dual-chambered implantable defibrillators, and biventricular implantable defibrillators. Single-chamber implantable defibrillators have only one right ventricular ICD shocking coil lead placed inside the heart's right ventricle. These devices continuously monitor the patient's heart rate and rhythm and can deliver electrical shocks to the heart. The main procedures for implantation are trans-venous implantable defibrillators and subcutaneous implantable defibrillators, utilized by hospitals and clinics, ambulatory surgery centers, and other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable defibrillators market research report is one of a series of new reports from The Business Research Company that provides implantable defibrillators market statistics, including implantable defibrillators industry global market size, regional shares, competitors with an implantable defibrillators market share, detailed implantable defibrillators market segments, market trends and opportunities, and any further data you may need to thrive in the implantable defibrillators industry. The implantable defibrillators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable defibrillators market size has grown steadily in recent years. It will grow from $5.54 billion in 2024 to $5.69 billion in 2025 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to the increased prevalence of cardiac disorders, clinical evidence and research, rise in the aging population, increased awareness and education, collaborations and partnerships.

The implantable defibrillators market size is expected to see strong growth in the next few years. It will grow to $7.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to remote monitoring and telemedicine integration, expansion of indications, focus on heart failure management, personalized medicine approaches, and global expansion of healthcare infrastructure. Major trends in the forecast period include miniaturization and design innovations, remote monitoring and connectivity, personalized therapy approaches, leadless implantable defibrillators, and battery technology advancements.

The forecast of 6.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-voltage capacitors and titanium alloy housings, sourced from key regions such as Japan and Sweden, which could lead to reduced availability of life-saving cardiac devices and higher prices for sudden cardiac arrest prevention.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected rise in the prevalence of sudden cardiac arrest is poised to drive the growth of the implantable defibrillators market. Sudden cardiac arrest (SCA) is a condition where the heart unexpectedly stops beating, and implantable defibrillators play a vital role in providing lifesaving therapy by detecting and correcting abnormal heart rhythms that may lead to SCA. According to a report by the Journal of the American College of Cardiology, SCD causes 185,000 to 450,000 deaths annually in the US population, accounting for 7% to 18% of all fatalities. Therefore, the increasing prevalence of sudden cardiac arrest is a significant factor propelling the growth of the implantable defibrillators market.

The rising incidence of diabetes is anticipated to drive the expansion of the implantable defibrillators market in the future. Diabetes is a chronic metabolic condition characterized by high blood glucose or sugar levels, which can lead to significant damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Implantable cardioverter defibrillators (ICDs) are vital for managing patients with diabetes, especially those who are at risk of sudden cardiac death. Research has demonstrated that ICDs can effectively lower the rates of arrhythmic death and overall mortality in patients with severe myocardial dysfunction, including those with diabetes. For example, in June 2024, NHS England, a governing body in the UK, reported that in 2023, 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycemia, also known as pre-diabetes, which represents an increase from 3,065,825 in 2022-an approximate rise of 18%. Consequently, the growing prevalence of diabetes is fueling the growth of the implantable defibrillators market.

A noteworthy trend in the implantable defibrillators market is the emphasis on product innovations by major companies. These companies are focusing on developing new products to maintain their competitive edge. For example, in December 2023, Medtronic, an Ireland-based medical device company, introduced a novel type of implantable cardioverter-defibrillator called the Aurora extravascular ICD. Unsuch as traditional transvenous ICDs, this device is inserted under the skin beneath the left armpit, providing defibrillation during cardiac arrest and ongoing pacemaker therapies. It features Epsila leads that are minimally invasively connected to the heart beneath the breastbone. Additionally, the implant incorporates Medtronic's Smart Sense technology, aimed at reducing the risk of unwarranted shocks, and SureScan technology, allowing patients to undergo MRI tests with the device in place.

Major companies operating in the implantable defibrillators market are also focused on introducing advanced Cardiac Rhythm Management (CRM) devices with cutting-edge features to drive market revenues. These devices, equipped with innovative technology, monitor and manage cardiac issues effectively. For instance, in October 2023, MicroPort CRM, a France-based developer and manufacturer of cardiac pacemakers and implantable cardiac defibrillators, launched the ULYS Implantable Cardioverter Defibrillator (ICDs) and the INVICTA defibrillation lead in Japan. The ULYS ICD, with its cutting-edge technology and low current consumption, is expected to have a significantly longer lifespan than conventional ICD devices. The INVICTA defibrillation lead, designed to continuously detect electrical signals from the heart's right ventricle, provides defibrillation shocks or pacing therapy in the case of a potentially fatal ventricular tachyarrhythmia.

In December 2022, Johnson & Johnson Services Inc., a US-based healthcare product manufacturer, completed the acquisition of Abiomed for $16.6 billion. This strategic move allowed Johnson & Johnson to enhance its global market-leading Biosense Webster electrophysiology business by adding heart recovery technologies from Abiomed, expanding its portfolio in rapidly growing cardiovascular areas, including implantable defibrillators. Abiomed is a US-based provider of cardiovascular medical technology specializing in treating heart failure and coronary artery disease.

Major companies operating in the implantable defibrillators market include Boston Scientific Corporation, LivaNova PLC, Biotronik SE & Co KG, MicroPort Scientific Corporation, Medtronic plc, St. Jude Medical Inc., Abbott Laboratories, Sorin Group Italia S.r.l., Nihon Kohden Corporation, Koninklijke Philips N.V., Fukuda Denshi Co Ltd., Progetti S.r.l., Imricor Medical Systems Inc., ZOLL Medical Corporation, Physio-Control International Inc., Cardiac Science Corporation, Defibtech LLC, HeartSine Technologies LLC, Schiller AG, CU Medical Systems Inc., Mindray Medical International Limited, Shenzhen Mindray Bio-Medical Electronics Co Ltd., Beijing M&B Electronic Instruments Co Ltd., Bexen Cardio SL, Pacemaker Technologies, EBR Systems Inc.

North America was the largest region in the implantable defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global implanted defibrillator market forecast period. The regions covered in the implantable defibrillators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable defibrillators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable defibrillator market consists of sales of epicardial implantable cardioverter-defibrillator, substernal implantable cardioverter-defibrillator, and single-chamber ICD with atrial sensing. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Defibrillators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable defibrillators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable defibrillators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable defibrillators market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Chambered Implantable Defibrillators; Dual Chambered Implantable Defibrillators; Biventricular Implantable Defibrillators
  • 2) By Procedure Type: Trans-Venous Implantable Defibrillators; Subcutaneous Implantable Defibrillators
  • 3) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
  • Subsegments:
  • 1) By Single Chambered Implantable Defibrillators: Standard Single Chamber ICDs; Leadless Single Chamber ICDs
  • 2) By Dual Chambered Implantable Defibrillators: Standard Dual Chamber ICDs; Advanced Dual Chamber ICDs
  • 3) By Biventricular Implantable Defibrillators: Standard Biventricular ICDs; Advanced Biventricular ICDs With CRT
  • Companies Mentioned: Boston Scientific Corporation; LivaNova PLC; Biotronik SE & Co KG; MicroPort Scientific Corporation; Medtronic plc; St. Jude Medical Inc.; Abbott Laboratories; Sorin Group Italia S.r.l.; Nihon Kohden Corporation; Koninklijke Philips N.V.; Fukuda Denshi Co Ltd.; Progetti S.r.l.; Imricor Medical Systems Inc.; ZOLL Medical Corporation; Physio-Control International Inc.; Cardiac Science Corporation; Defibtech LLC; HeartSine Technologies LLC; Schiller AG; CU Medical Systems Inc.; Mindray Medical International Limited; Shenzhen Mindray Bio-Medical Electronics Co Ltd.; Beijing M&B Electronic Instruments Co Ltd.; Bexen Cardio SL; Pacemaker Technologies; EBR Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Defibrillators Market Characteristics

3. Implantable Defibrillators Market Trends And Strategies

4. Implantable Defibrillators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Defibrillators Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Defibrillators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Defibrillators Market Growth Rate Analysis
  • 5.4. Global Implantable Defibrillators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Defibrillators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Defibrillators Total Addressable Market (TAM)

6. Implantable Defibrillators Market Segmentation

  • 6.1. Global Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Chambered Implantable Defibrillators
  • Dual Chambered Implantable Defibrillators
  • Biventricular Implantable Defibrillators
  • 6.2. Global Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trans-Venous Implantable Defibrillators
  • Subcutaneous Implantable Defibrillators
  • 6.3. Global Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgery Centers
  • Other End Users
  • 6.4. Global Implantable Defibrillators Market, Sub-Segmentation Of Single Chambered Implantable Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Single Chamber ICDs
  • Leadless Single Chamber ICDs
  • 6.5. Global Implantable Defibrillators Market, Sub-Segmentation Of Dual Chambered Implantable Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Dual Chamber ICDs
  • Advanced Dual Chamber ICDs
  • 6.6. Global Implantable Defibrillators Market, Sub-Segmentation Of Biventricular Implantable Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Biventricular ICDs
  • Advanced Biventricular ICDs With CRT

7. Implantable Defibrillators Market Regional And Country Analysis

  • 7.1. Global Implantable Defibrillators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Defibrillators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Defibrillators Market

  • 8.1. Asia-Pacific Implantable Defibrillators Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Defibrillators Market

  • 9.1. China Implantable Defibrillators Market Overview
  • 9.2. China Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Defibrillators Market

  • 10.1. India Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Defibrillators Market

  • 11.1. Japan Implantable Defibrillators Market Overview
  • 11.2. Japan Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Defibrillators Market

  • 12.1. Australia Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Defibrillators Market

  • 13.1. Indonesia Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Defibrillators Market

  • 14.1. South Korea Implantable Defibrillators Market Overview
  • 14.2. South Korea Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Defibrillators Market

  • 15.1. Western Europe Implantable Defibrillators Market Overview
  • 15.2. Western Europe Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Defibrillators Market

  • 16.1. UK Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Defibrillators Market

  • 17.1. Germany Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Defibrillators Market

  • 18.1. France Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Defibrillators Market

  • 19.1. Italy Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Defibrillators Market

  • 20.1. Spain Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Defibrillators Market

  • 21.1. Eastern Europe Implantable Defibrillators Market Overview
  • 21.2. Eastern Europe Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Defibrillators Market

  • 22.1. Russia Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Defibrillators Market

  • 23.1. North America Implantable Defibrillators Market Overview
  • 23.2. North America Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Defibrillators Market

  • 24.1. USA Implantable Defibrillators Market Overview
  • 24.2. USA Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Defibrillators Market

  • 25.1. Canada Implantable Defibrillators Market Overview
  • 25.2. Canada Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Defibrillators Market

  • 26.1. South America Implantable Defibrillators Market Overview
  • 26.2. South America Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Defibrillators Market

  • 27.1. Brazil Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Defibrillators Market

  • 28.1. Middle East Implantable Defibrillators Market Overview
  • 28.2. Middle East Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Defibrillators Market

  • 29.1. Africa Implantable Defibrillators Market Overview
  • 29.2. Africa Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Defibrillators Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Defibrillators Market Competitive Landscape
  • 30.2. Implantable Defibrillators Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biotronik SE & Co KG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. MicroPort Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Defibrillators Market Other Major And Innovative Companies

  • 31.1. St. Jude Medical Inc.
  • 31.2. Abbott Laboratories
  • 31.3. Sorin Group Italia S.r.l.
  • 31.4. Nihon Kohden Corporation
  • 31.5. Koninklijke Philips N.V.
  • 31.6. Fukuda Denshi Co Ltd.
  • 31.7. Progetti S.r.l.
  • 31.8. Imricor Medical Systems Inc.
  • 31.9. ZOLL Medical Corporation
  • 31.10. Physio-Control International Inc.
  • 31.11. Cardiac Science Corporation
  • 31.12. Defibtech LLC
  • 31.13. HeartSine Technologies LLC
  • 31.14. Schiller AG
  • 31.15. CU Medical Systems Inc.

32. Global Implantable Defibrillators Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Defibrillators Market

34. Recent Developments In The Implantable Defibrillators Market

35. Implantable Defibrillators Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Defibrillators Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Defibrillators Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Defibrillators Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer